These effects, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the concept of focusing on ACKR3 as a novel way to modulate the opioid system, which could open up new therapeutic avenues for opioid-relevant disorders. By ticking this box https://lordi369vrn9.gigswiki.com/user